Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa-machi, Maebashi, 371-8511, Japan.
Department of Health, Gunma University Graduate School of Health Science, Maebashi, Japan.
ESC Heart Fail. 2022 Apr;9(2):1454-1462. doi: 10.1002/ehf2.13853. Epub 2022 Feb 15.
Right-sided filling pressure is elevated in some patients with heart failure (HF) and preserved ejection fraction (HFpEF). We hypothesized that right atrial pressure (RAP) would represent the cumulative burden of abnormalities in the left heart, pulmonary vasculature, and the right heart.
Echocardiography was performed in 399 patients with HFpEF. RAP was estimated from inferior vena cava morphology and its respiratory change [estimated right atrial pressure (eRAP)], and patients were divided according to eRAP (3 or ≥8 mmHg). Patients with higher eRAP displayed more severe abnormalities in LV diastolic function as well as right heart structure and function than those with normal eRAP. Cardiac deaths or HF hospitalization occurred in 84 patients over a median follow-up of 19.0 months (interquartile range 6.7-36.9). The presence of higher eRAP was independently associated with an increased risk of the composite outcome (adjusted hazard ratio 2.20 vs. normal eRAP group, 95% confidence interval 1.34-3.62, P = 0.002). Kaplan-Meier curves separating the patients into four groups based on eRAP and E/e' ratio showed that event-free survival varied among the groups, providing an incremental prognostic value of eRAP over E/e' ratio. The classification and regression tree analysis demonstrated that eRAP was the strongest predictor of the outcome followed by right ventricular dimension, E/e' ratio, and estimated right ventricular systolic pressure, stratifying the patients into four risk groups (incident rate 8.8-72.2%).
These data may provide new insights into the prognostic role of RAP in the complex pathophysiology of HFpEF and suggest the utility of eRAP for the risk stratification in patients with HFpEF.
一些射血分数保留的心衰(HFpEF)患者存在右侧充盈压升高。我们假设右心房压(RAP)可以代表左心、肺血管和右心异常的累积负担。
对 399 例 HFpEF 患者进行了超声心动图检查。RAP 由下腔静脉形态及其呼吸变化[估计右心房压(eRAP)]来估计,并根据 eRAP (3 或≥8mmHg)将患者进行分组。与 eRAP 正常的患者相比,eRAP 较高的患者左室舒张功能以及右心结构和功能的异常更为严重。中位随访 19.0 个月(四分位距 6.7-36.9)期间,84 例患者发生心脏死亡或 HF 住院。eRAP 较高的存在与复合终点风险增加独立相关(校正后 HR 2.20,正常 eRAP 组为 1.34-3.62,P=0.002)。根据 eRAP 和 E/e' 比值将患者分为四组的 Kaplan-Meier 曲线显示,各组之间的无事件生存率不同,提示 eRAP 比 E/e' 比值具有额外的预后价值。分类回归树分析表明,eRAP 是继右心室舒张末期内径、E/e' 比值和估测右心室收缩压之后最强的预后预测因子,将患者分为四个风险组(发生率 8.8-72.2%)。
这些数据可能为 RAP 在 HFpEF 复杂病理生理学中的预后作用提供新的见解,并提示 eRAP 对 HFpEF 患者的风险分层有用。